Investing.com - Financial Markets Worldwide

Krynica Vitamin SA (KVT)

Warsaw
Currency in PLN
9.98
-0.02(-0.20%)
Closed·

KVT Financial Summary

Key Ratios

P/E Ratio8.27
Price/Book1.24
Debt / Equity43.03%
Return on Equity16.28%
Dividend Yield2.71%
EBITDA32.81M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa445.94395.31377.16357.12387.89
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa119.6158.5366.2552.4964.36
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa75.6123.3920.888.6119.19
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa56.9315.5813.08-6.6812.23
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa210.45227.3233.06227.6224.33
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa91.26109.48106.23117.67109.05
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa84.5677.8590.9381.894.03
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa46.24-11.59-11.0419.6611.39
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa74.2613.6214.3924.1931
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-15.82-16.4-14.73-8.92-10.5
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-52.87-1.45-0.97-13.56-22.76
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa5.56-4.23-1.311.7-2.26
* In Millions of PLN (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.17%
Dividend Yield
2.71%
Industry Median 2.85%
Annualised payout
0.27
Paid annually
5-Years Growth
+2.38%
Growth Streak
Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
0.08 / --
Revenue / Forecast
79.60M / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Krynica Vitamin SA's earnings for the latest quarter?

The Krynica Vitamin SA EPS (TTM) is 1.17. Krynica Vitamin SA reported sales of 79.60, net income of 0.92, and EPS of 0.08 for the latest quarter.

What was Krynica Vitamin SA's net income for the latest quarter?

Krynica Vitamin SA's net income for the latest quarter was 0.92.

How did Krynica Vitamin SA's performance compare year-over-year in the latest quarter?

The company's revenue moved from 86.35 in the previous quarter to 79.60 in the latest quarter, and net income moved from 0.71 to 0.92 compared to the previous quarter.

What is Krynica Vitamin SA's net profit margin on a TTM basis?

Krynica Vitamin SA's trailing twelve months (TTM) net profit margin is 3.15%.

How does Krynica Vitamin SA's debt to equity ratio compare to industry standards?

Krynica Vitamin SA's total debt-to-equity ratio is 43.03%.

What is Krynica Vitamin SA's return on investment on a TTM basis?

Krynica Vitamin SA's trailing twelve months (TTM) return on investment (ROI) is 16.28%.

Did Krynica Vitamin SA gain or lose cash last quarter?

In the latest quarter, Krynica Vitamin SA's net change in cash was -0.17 million.

What were Krynica Vitamin SA's total assets and liabilities in the latest quarter?

As of the latest quarter, Krynica Vitamin SA reported total assets of 220.75 million and total liabilities of 107.25 million.

How has Krynica Vitamin SA's total revenue grown this year?

Krynica Vitamin SA's total revenue was 86.35 in the previous quarter and 79.60 in the latest quarter.

What is Krynica Vitamin SA's gross margin on a TTM basis?

Krynica Vitamin SA's trailing twelve months (TTM) gross margin is 16.92%.

What was Krynica Vitamin SA's revenue per share for the latest quarter?

Krynica Vitamin SA's revenue per share for the latest quarter was 10.93.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.